Understanding cross-country differences in health status and expenditures

Arbeitspapier

Using a general equilibrium heterogeneous agent model featuring health production, we quantify the relative contribution of price distortions in the health market, TFP and other health risks in explaining cross-country differences in health expenditure (as a share of GDP) and health status. Estimated parameters reveal a substantial price wedge that explains at most 20% of the difference in health spending (as a share of GDP) and 30% of the difference in health status between Europe and the U.S. We estimate a one percentage point negative impact on the life-time cost-of-living of Americans from higher prices due to inefficiencies.

Object Details

• Language: Englisch

References and Relationships

• Bibliographic citation: Series: Document de travail ; No. 2020-06

Classification and Topics

• Classification: Wirtschaft ; Model Construction and Estimation ; Allocative Efficiency; Cost-Benefit Analysis ; Macroeconomics: Consumption; Saving; Wealth ; Health: General ; Measurement and Analysis of Poverty
• Subject: Health production ; health status ; heterogeneous agent model ; price indices

Contributors, Places and Time

• Event: Geistige Schöpfung
• (who): Fonseca, Raquel ; Langot, François ; Michaud, Pierre-Carl ; Sopraseuth, Thepthida
• Event: Veröffentlichung
• (who): Université du Québec à Montréal, École des sciences de la gestion (ESG UQAM), Département des sciences économiques
• (where): Montréal
• (when): 2020

Further information

• Handle: http://hdl.handle.net/10419/234806
• Last update: 10.03.2025, 11:43 AM CET